Abstract
Inflammation is an essential process for survival and for the physiological defense against pathogens. After early reports by Virchow suggesting a functional connection between inflammation and cancer, the pathological role of inflammation in promoting tumor growth and invasion has recently again entered the focus of attention. There is now clear evidence that one essential contribution of the inflammatory infiltrate to tumor growth is the stimulation of angiogenesis. Different cell types of the innate immune system, particularly macrophages, mast cells, and neurophils, play an active role in enhancing tumor angiogenesis — either directly, via the release of vesicle-stored growth factors, cytokines and proteolytic enzymes, or indirectly, via paracrine signalling cascades. This concept of an indirect inflammation-dependent induction of angiogenesis places inflammation as a target for tumor therapy and, even better, for the prevention of tumor angiogenesis by anti-inflammatory agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albini A, Tosetti F, Benelli R, Noonan DM (2005) Tumor inflammatory angiogenesis and its chemoprevention. Can-cer Res 65:10637–10641
Allavena P, Sica A, Vecchi A, Locati M, Sozzani S, Mantovani A (2000) The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol Rev 177:141–149
Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED et al (2000) Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6:1755–1766
Balkwill F (2002) Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13:135–141
Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:211–217
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252
Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S et al (1999) In breast carcinoma tissue, immature den-dritic cells reside within the tumor, whereas mature den-dritic cells are located in peritumoral areas. J Exp Med 190:1417–1426
Bellocq A, Antoine M, Flahault A, Philippe C, Crestani B, Bernaudin JF et al (1998) Neutrophil alveolitis in bron-chioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol 152:83–92
Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implica-tions for new anticancer therapies. J Pathol 196:254–265
Boccaccio C, Sabatino G, Medico E, Girolami F, Follenzi A, Reato G et al (2005) The MET oncogene drives a ge-netic programme linking cancer to haemostasis. Nature 434:396–400
Burke B, Giannoudis A, Corke KP, Gill D, Wells M, Ziegler-Heitbrock L et al (2003) Hypoxia-induced gene expres-sion in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 163:1233–1243
Burke B, Tang N, Corke KP, Tazzyman D, Ameri K, Wells M et al (2002) Expression of HIF-1alpha by human macro-phages: implications for the use of macrophages in hy-poxia-regulated cancer gene therapy. J Pathol 196:204–212
Caruso RA, Bellocco R, Pagano M, Bertoli G, Rigoli L, Infer-rera C (2002) Prognostic value of intratumoral neutro-phils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol 15:831–837
Clevers H (2004) At the crossroads of inflammation and can-cer. Cell 118:671–674
Coussens LM, Hanahan D, Arbeit JM (1996) Genetic pre-disposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am J Pathol 149:1899–1917
Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z et al (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithe-lial carcinogenesis. Genes Dev 13:1382–1397
Coussens LM, Tinkle CL, Hanahan D, Werb Z (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481–490
Dalgleish AG, O’Byrne KJ (2002) Chronic immune activa-tion and inflammation in the pathogenesis of AIDS and cancer. Adv Cancer Res 84:231–276
DeVisser KE, Korets LV, Coussens LM (2005) De novo car-cinogenesis promoted by chronic inflammation is B lym-phocyte dependent. Cancer Cell 7:411–423
Enk AH, Jonuleit H, Saloga J, Knop J (1997) Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 73:309–316
Ferrara N, Hillan KJ, Gerber HP, Novotny W (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3:391–400
Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G et al (2006) Angiopoietin-2 sensitizes endo-thelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12:235–239
Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer MD et al (2000) The urokinase system of plas-minogen activation and prognosis in 2780 breast cancer patients. Cancer Res 60:636–643
Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pix-ley FJ et al (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65:5278–5283
Gupta RA, Dubois RN (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1:11–21
Gutschalk CM, Herold-Mende CC, Fusenig NE, Muel-ler MM (2006) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating fac-tor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res 66:8026–8036
Hackstein H, Morelli AE, Thomson AW (2001) Designer den-dritic cells for tolerance induction: guided not misguided missiles. Trends Immunol 22:437–442
Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N, No-mura Y (2000) Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 7:263–269
Hanahan D, Folkman J (1996) Patterns and emerging mech-anisms of the angiogenic switch during tumorigenesis. Cell 86:353–364
Heryanto B, Girling JE, Rogers PA (2004) Intravascular neu-trophils partially mediate the endometrial endothelial cell proliferative response to oestrogen in ovariectomised mice. Reproduction 127:613–620
Hildenbrand R, Glienke W, Magdolen V, Graeff H, Stutte HJ, Schmitt M (1998) Urokinase receptor localization in breast cancer and benign lesions assessed by in situ hy-bridization and immunohistochemistry. Histochem Cell Biol 110:27–32
Hiromatsu Y, Toda S (2003) Mast cells and angiogenesis. Mi-crosc Res Tech 60:64–69
Hooper LV, Stappenbeck TS, Hong CV, Gordon JI (2003) An-giogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4:269–273
Huegel R, Velasco P, de la Luz Sierra M, Christophers E, Sch-roder JM, Schwarz T et al (2006) Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin. J In-vest Dermatol 127:65–74
Imada A, Shijubo N, Kojima H, Abe S (2000) Mast cells cor-relate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J 15:1087–1093
Iwatsuki K, Kumara E, Yoshimine T, Nakagawa H, Sato M, Hayakawa T (2000) Elastase expression by infiltrating neutrophils in gliomas. Neurol Res 22:465–468
Kankkunen JP, Harvima IT, Naukkarinen A (1997) Quanti-tative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 72:385–388
Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S (2004) Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 99:1667–1674
Korff T, Augustin HG (1999) Tensional forces in fibrillar ex-tracellular matrices control directional capillary sprout-ing. J Cell Sci 112:3249–3258
Lachter J, Stein M, Lichtig C, Eidelman S, Munichor M (1995) Mast cells in colorectal neoplasias and premalignant dis-orders. Dis Colon Rectum 38:290–293
Lanone S, Zheng T, Zhu Z, Liu W, Lee CG, Ma B et al (2002) Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and-12 in IL-13-induced inflamma-tion and remodeling. J Clin Invest 110:463–474
Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast car-cinoma. Cancer Res 56:4625–4629
Leek RD, Landers RJ, Harris AL, Lewis CE (1999) Necrosis correlates with high vascular density and focal macro-phage infiltration in invasive carcinoma of the breast. Br J Cancer 79:991–995
Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA, Har-ris AL (2000) Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 190:430–436
Lespagnard L, Gancberg D, Rouas G, Leclercq G, de Saint-Aubain Somerhausen N, di Leo A et al (1999) Tumor-infil-trating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int J Cancer 84:309–314
Lewis C, Murdoch C (2005) Macrophage responses to hy-poxia: implications for tumor progression and anti-can-cer therapies. Am J Pathol 167:627–635
Lewis C, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res66:605–612
Lewis C, Leek R, Harris A, McGee JO (1995) Cytokine regula-tion of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 57:747–751
Liu XH, Kirschenbaum A, Lu M, Yao S, Dosoretz A, Hol-land JF et al (2002) Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear local-ization in a human prostate cancer cell line. J Biol Chem 277:50081–50086
Locati M, Deuschle U, Massardi ML, Martinez FO, Sironi M, Sozzani S et al (2002) Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Im-munol 168:3557–3562
Macarthur M, Hold GL, E1-Omar EM (2004) Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointesti-nal malignancy. Am J Physiol Gastrointest Liver Physiol 286:G515–G520
Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549–555
Mantovani A, Allavena P, Sica A (2004) Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur J Cancer 40:1660–1667
Masson V, dela Ballina LR, Munaut C, Wielockx B, Jost M, Maillard C et al (2005) Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J 19:234–236
Meininger CJ, Zetter BR (1992) Mast cells and angiogenesis. Semin Cancer Biol 3:73–79
Mueller MM (2006) Inflammation in epithelial skin tumours: old stories and new ideas. Eur J Cancer 42:735–744
Mueller MM, Fusenig NE (2002) Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 70:486–497
Mueller MM, Fusenig NE (2004) Friends or foes — bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839–849
Murdoch C, Giannoudis A, Lewis CE (2004) Mechanisms regulating the recruitment of macrophages into hy-poxic areas of tumors and other ischemic tissues. Blood 104:2224–2234
Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura YN, Hamano S et al (2005) Infiltration of COX-2-express-ing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest 115:2979–2991
Negus RP, Stamp GW, Hadley J, Balkwill FR (1997) Quan-titative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C che-mokines. Am J Pathol 150:1723–1734
Nielsen HJ, Hansen U, Christensen IJ, Reimert CM, Brunner N, Moesgaard F (1999) Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 189:487–495
Nienartowicz A, Sobaniec-Lotowska ME, Jarocka-Cyrta E, Lemancewicz D (2006) Mast cells in neoangiogenesis. Med Sci Monit 12:RA53–RA56
Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H et al (1999) Macrophage infiltration and heme oxygen-ase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 5:1107–1113
Nishizuka I, Ichikawa Y, Ishikawa T, Kamiyama M, Hasegawa S, Momiyama N et al (2001) Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and in-duces angiogenesis in vivo. Cancer Lett 173:175–182
Nozawa H, Chiu C, Hanahan D (2006) Infiltrating neutro-phils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103:12493–12398
Obermueller E, Vosseler S, Fusenig NE, Mueller MM(2004) Cooperative autocrine and paracrine functions of gran-ulocyte colony-stimulating factor and granulocyte-mac-rophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res 64:7801–7812
Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, Hicklin DJ et al (2005) Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 19:2005–2007
Ohno S, Ohno Y, Suzuki N, Kamei T, Koike K, Inagawa H et al (2004) Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 24:3335–3342
O’Sullivan C, Lewis CE, Harris AL, McGee JO (1993) Secre-tion of epidermal growth factor by macrophages associ-ated with breast carcinoma. Lancet 342:148–149
Pollard JW (2004) Tumour-educated macrophages promote tu-mour progression and metastasis. Nat Rev Cancer 4:71–78
Rajashekhar G, Willuweit A, Patterson CE, Sun P, Hilbig A, Breier G et al (2006) Continuous endothelial cell activa-tion increases angiogenesis: evidence for the direct role of endothelium linking angiogenesis and inflammation. J Vasc Res 43:193–204
Ribatti D, Vacca A, Nico B, Crivellato E, Roneali L, Dam-macco F (2001a) The role of mast cells in tumour angio-genesis. Br J Haematol 115:514–521
Ribatti D, Crivellato E, Candussio L, Nico B, Vacca A, Ron-cali L et al (2001b) Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic mem-brane. Clin Exp Allergy 31:602–608
Riboldi E, Musso T, Moroni E, Urbinati C, Bernasconi S, Rus-nati M, et al (2005) Cutting edge: proangiogenic proper-ties of alternatively activated dendritic cells. J Immunol 175:2788–2792
Roche WR (1985) Mast cells and tumour angiogenesis: the tumor-mediated release of an endothelial growth factor from mast cells. Int J Cancer 36:721–728
Ross JA, Auger MJ (2002) The biology of the macrophage. In: Burke B, Lewis CE (eds) The macrophage.kOxford Univer-sity Press, Oxford
Scapini P, Nesi L, Morini M, Tanghetti E, Belleri M, Noonan D et al (2002) Generation of biologically active angio-statin kringle 1–3 by activated human neutrophils. J Im-munol 168:5798–5804
Scapini P, Morini M, Tecchio C, Minghelli S, di Carlo E, Tanghetti E et al (2004) CXCLl/macrophage inflamma-tory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth fac-tor-A. J Immunol 172:5034–5040
Scarpino S, Stoppacciaro A, Ballerini F, Marchesi M, Prat M, Stella MC et al (2000) Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells. Am J Pathol 156:831–837
Schaider H, Oka M, Bogenrieder T, Nesbit M, Satyamoorthy K, Berking C et al (2003) Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer 103:335–343
Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C et al (2002) Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161:947–956
Schruefer R, Lutze N, Schymeinsky J, Walzog B (2005) Human neutrophils promote angiogenesis by a paracrine feed-forward mechanism involving endothelial interleukin-8. Am J Physiol Heart Circ Physiol 288:H1186–H1192
Schruefer R, Sulyok S, Schymeinsky J, Peters T, Scharffetter-Kochanek K, Walzog B (2006) The proangiogenic capacity of polymorphonuclear neutrophils delineated by microar-ray technique and by measurement of neovascularization in wounded skin of CD 18-deficient mice. J Vasc Res 43:1–11
Schwaab T, Schned AR, Heaney JA, Cole BF, Atzpodien J, Wittke F et al (1999) In vivo description of dendritic cells in human renal cell carcinoma. J Urol 162:567–573
Shijubo N, Kojima H, Nagata M, Ohchi T, Suzuki A, Abe S et al (2003) Tumor angiogenesis of non-small cell lung cancer. Microsc Res Tech 60:186–198
Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised pop-ulation promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717–727
Starkey JR, Crowle PK, Taubenberger S (1988) Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 42:48–52
Sugar LM (2006) Inflammation and prostate cancer. Can J Urol 13[Suppl 1]:46–47
Sunderkotter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C (1991) Macrophage-derived angiogenesis factors. Pharmacol Ther 51:195–216
Troy A, Davidson P, Atkinson C, Hart D (1998) Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer. J Urol 160:214–219
Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y, Sugimachi K (1990) Infiltration of dendritic cells in re-lation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer 66:2012–2016
Turini ME, DuBois RN (2002) Cyclooxygenase-2: a therapeu-tic target. Annu Rev Med 53:35–57
Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A et al (2002) Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin In-vest 109:777–785
Vicari AP, Caux C (2002) Chemokines in cancer. Cytokine Growth Factor Rev 13:143–154
Virchow R (1862/1863) Die krankhaften Geschwülste: 30 Vorlesungen gehalten während des Wintersemesters 1862/1863. Hirschwald, Berlin (Vorlesungen über Pa-thologie; 3,1; 3,2)
Vosseier S, Mirancea N, Bohlen P, Mueller MM, Fusenig NE (2005) Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal ma-trix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Res 65:1294–1305
Wang W, Bergh A, Damber JE (2005) Cyclooxygenase-2 ex-pression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin Cancer Res 11:3250–3256
White JR, Harris RA, Lee SR, Craigon MH, Binley K, Price T et al (2004) Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regu-lators of angiogenesis. Genomics 83:1–8
Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L (2000) Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 80:617–653
Yamamoto T, Katayama I, Nishioka K (1997) Expression of stem cell factor in basal cell carcinoma. Br J Dermatol 137:709–713
Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentru-ber DJ, Topalian SL et al (2003) A randomized trial of bevacizumab, an anti-vascular endothelial growth fac-tor antibody, for metastatic renal cancer. N Engl J Med 349:427–434
Zittermann SI, Issekutz AC (2006) Endothelial growth fac-tors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation. J Leukoc Biol 80:247–257
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mueller, M. (2008). Inflammation and Angiogenesis: Innate Immune Cells as Modulators of Tumor Vascularization. In: Marmé, D., Fusenig, N. (eds) Tumor Angiogenesis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33177-3_20
Download citation
DOI: https://doi.org/10.1007/978-3-540-33177-3_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33176-6
Online ISBN: 978-3-540-33177-3
eBook Packages: MedicineMedicine (R0)